Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

opigolix MeSH Supplementary Concept Data 2025


MeSH Supplementary
opigolix
Unique ID
C000708087
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000708087
Entry Term(s)
(1Z,2R)-N'-((5-(3-(2,5-Difluorophenyl)-2-(1,3-dihydro-2H-benzimidazol-2-ylidene)-3-oxopropanoyl)-2-fluorophenyl)sulfonyl)-2-hydroxypropanimidamide
ASP1707
propanimidamide, N'-((5-(3-(2,5-difluorophenyl)-2-(1,3-dihydro-2H-benzimidazol-2-ylidene)-1,3-dioxopropyl)-2-fluorophenyl)sulfonyl)-2-hydroxy-, (1Z,2R)-
Registry Numbers
VQ6CK0CITA
Heading Mapped to
*Imidazoles
*Sulfones
Frequency
3
Note
GnRH antagonist
Source
Hum Reprod. 2019 May 1;34(5):813-823.
Date of Entry
2020/07/01
Revision Date
2020/07/01
opigolix Preferred
ASP1707 Narrower
(1Z,2R)-N'-((5-(3-(2,5-Difluorophenyl)-2-(1,3-dihydro-2H-benzimidazol-2-ylidene)-3-oxopropanoyl)-2-fluorophenyl)sulfonyl)-2-hydroxypropanimidamide Broader
page delivered in 0.005s